Prevalence of resistance markers of artemisinin, partner drugs, and sulfadoxine-pyrimethamine in Nanyumbu and Masasi Districts, Tanzania between 2020 and 2021
Antimicrobial Agents and Chemotherapy · 2025-10 · 69 (10)
DOI: 10.1128/aac.01751-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025-10. Verfasst von Richard O Mwaiswelo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Parasitology, School of Medicine, Kairuki University, Dar es Salaam, Tanzania. Hauptthemen laut MEDLINE: Pyrimethamine, Sulfadoxine, Plasmodium falciparum, Antimalarials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Regular monitoring of the emergence and spread of Plasmodium falciparum markers of resistance against artemisinin, partner drugs, sulfadoxine, and pyrimethamine is important for the treatment and prevention of malaria in Tanzania. Blood samples were collected from febrile and non-febrile children aged 3 to 59 months in Masasi and Nanyumbu Districts between 2020 and 2021. The samples were subjected to molecular analysis for markers of artemisinin, partner drugs, sulfadoxine, and pyrimethamine resistance, including Plasmodium falciparum kelch ( Pfk ) 13 gene, P. falciparum chloroquine resistance transporter gene ( Pfcrt ), P. falciparum multidrug resistance gene ( Pfmdr ) 1, P. falciparum dihydrofolate reductase ( Pfdhfr ), and P. falciparum dihydropteroate synthase ( Pfdhps ). A total of 531 blood samples were involved in the analysis. None of the P. falciparum isolates analyzed for Pfk13 carried any of the validated markers of artemisinin resistance. Pfcrt CVMNK wild-type haplotype occurred in 88.9% (271/305) of the parasites, and the mutant CVIET haplotype occurred only in 0.7% (2/305). Conversely, the majority of the parasites (24.2% [48/198]) were carrying Pfmdr1 NFD haplotype, followed by the wild-type haplotype NYD (19.1% (39/198), and the rest were mixed infections. Quintuple mutation IRN I-S GE AA occurred in 54.4% (62/114), and sextuple mutation IRN I- F AK GS occurred only in 0.9% (1/114) of the parasites. No parasite carried any of the validated markers of artemisinin resistance; however, the prevalence of Pfcrt and Pfmdr1 resistance markers against the partner drugs reached the saturation point. Sextuple Pfdhfr-Pfdhps mutations occurred only in one patient; therefore, SP remains efficacious for IPTp in the Districts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Parasitology, School of Medicine, Kairuki University, Dar es Salaam, Tanzania.
- Tanga Research Centre, National Instititute for Medical Research, Tanga, Tanzania.
- National Malaria Control Programme, Ministry of Health, Dodoma, Tanzania.
- Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
- Genomic Surveillance Unit, Wellcome Sanger Institute, Cambridge, United Kingdom.
ORCID-Profile: Richard O Mwaiswelo
Zitieren
APA
Mwaiswelo, R. O., Mmbando, B. P., Chacky, F., Molteni, F., Mohamed, A., Lazaro, S., Samuel, B., Ariani, C. V., Gonçalves, S., Drury, E., & Ngasala, B. (2025). Prevalence of resistance markers of artemisinin, partner drugs, and sulfadoxine-pyrimethamine in Nanyumbu and Masasi Districts, Tanzania between 2020 and 2021. Antimicrobial Agents and Chemotherapy, 69(10). https://doi.org/10.1128/aac.01751-24
Vancouver
Mwaiswelo RO, Mmbando BP, Chacky F, Molteni F, Mohamed A, Lazaro S, et al. Prevalence of resistance markers of artemisinin, partner drugs, and sulfadoxine-pyrimethamine in Nanyumbu and Masasi Districts, Tanzania between 2020 and 2021. Antimicrobial Agents and Chemotherapy. 2025;69(10). doi:10.1128/aac.01751-24
BibTeX
@article{Mwaiswelo2025,
author = {Mwaiswelo, Richard O and Mmbando, Bruno P and Chacky, Frank and Molteni, Fabrizio and Mohamed, Ally and Lazaro, Samwel and Samuel, Bushukatale and Ariani, Cristina V and Gonçalves, Sonia and Drury, Eleanor and Ngasala, Billy},
title = {Prevalence of resistance markers of artemisinin, partner drugs, and sulfadoxine-pyrimethamine in Nanyumbu and Masasi Districts, Tanzania between 2020 and 2021},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {10},
doi = {10.1128/aac.01751-24}
}
EUVIMED